Back
Oct 22, 2025
|
4:30 PM CEST
|
Virtual
Back
On October 22, 2025, Evaxion hosted a live webinar featuring a detailed presentation of the newly released two-year Phase 2 clinical data from EVX-01, our AI-designed personalised cancer vaccine for advanced melanoma. The session was led by Benjamin Wolthers, VP of Clinical Development at Evaxion, and Professor Adnan Khattak, who presented and discussed the key findings from the trial. Professor Khattak is a leading medical oncologist in Western Australia with subspecialty expertise in melanoma, gastrointestinal, hepatobiliary, and lung cancers, as well as immunotherapy and clinical trials.
Watch the recording below:
